77 related articles for article (PubMed ID: 6317229)
21. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
[TBL] [Abstract][Full Text] [Related]
22. Bilateral adrenocortical adenomas causing ACTH-independent Cushing's syndrome at different periods: a case report and discussion of corticosteroid replacement therapy following bilateral adrenalectomy.
Tung SC; Wang PW; Huang TL; Lee WC; Chen WJ
J Endocrinol Invest; 2004 Apr; 27(4):375-9. PubMed ID: 15233560
[TBL] [Abstract][Full Text] [Related]
23. Direct assay of cortisol in human saliva by solid phase radioimmunoassay and its clinical applications.
Hiramatsu R
Clin Chim Acta; 1981 Dec; 117(2):239-49. PubMed ID: 6273017
[TBL] [Abstract][Full Text] [Related]
24. 24-hour serum concentration profile of cortisol in patients with Cushing's disease.
Pirich K; Vierhapper H
Exp Clin Endocrinol; 1988 Mar; 92(3):275-9. PubMed ID: 2855318
[TBL] [Abstract][Full Text] [Related]
25. Plasma and salivary 6beta-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.
Varga I; Jakab C; Szücs N; Patócs A; Tóth M; Kiss R; Gláz E; Rácz K
Horm Metab Res; 2003 Jul; 35(7):421-6. PubMed ID: 12931273
[TBL] [Abstract][Full Text] [Related]
26. Combined amplification of the pulsatile and basal modes of adrenocorticotropin and cortisol secretion in patients with Cushing's disease: evidence for decreased responsiveness of the adrenal glands.
van den Berg G; Frölich M; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 1995 Dec; 80(12):3750-7. PubMed ID: 8530629
[TBL] [Abstract][Full Text] [Related]
27. Leptin secretion in Cushing's syndrome: preservation of diurnal rhythm and absent response to corticotropin-releasing hormone.
Weise M; Abad V; Considine RV; Nieman L; Rother KI
J Clin Endocrinol Metab; 1999 Jun; 84(6):2075-9. PubMed ID: 10372713
[TBL] [Abstract][Full Text] [Related]
28. A comparison of adrenal cortical function in patients with depressive illness and Cushing's disease.
Schlechte JA; Sherman B; Pfohl B
Horm Res; 1986; 23(1):1-8. PubMed ID: 3940937
[TBL] [Abstract][Full Text] [Related]
29. Apparently normal pituitary-adrenal suppressibility in Cushing's syndrome: dexamethasone metabolism and plasma levels.
Meikle AW; Lagerquist LG; Tyler FH
J Lab Clin Med; 1975 Sep; 86(3):472-8. PubMed ID: 1151162
[TBL] [Abstract][Full Text] [Related]
30. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
Castro M; Elias LL; Elias PC; Moreira AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
[TBL] [Abstract][Full Text] [Related]
31. Plasma testosterone profiles in Cushing's syndrome.
Smals AG; Kloppenborg PW; Benraad TJ
J Clin Endocrinol Metab; 1977 Aug; 45(2):240-5. PubMed ID: 195973
[TBL] [Abstract][Full Text] [Related]
32. Beta-lipotropin and cortisol responses to an intravenous infusion dexamethasone suppression test in Cushing's syndrome and obesity.
Abou Samra AB; Dechaud H; Estour B; Chalendar D; Fevre-Montange M; Pugeat M; Tourniaire J
J Clin Endocrinol Metab; 1985 Jul; 61(1):116-9. PubMed ID: 3998073
[TBL] [Abstract][Full Text] [Related]
33. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of canine Cushing's syndrome based on multiple steroid analysis and dexamethasone turnover kinetics.
Lothrop CD; Oliver JW
Am J Vet Res; 1984 Nov; 45(11):2304-9. PubMed ID: 6098199
[TBL] [Abstract][Full Text] [Related]
35. [The clinical significance of the radioimmunological determination of plasma ACTH (author's transl)].
Haydl H; Waldhäusl W
Wien Klin Wochenschr; 1975 Jun; 87(13):401-6. PubMed ID: 180698
[TBL] [Abstract][Full Text] [Related]
36. Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome.
Lacroix A; Bolté E; Tremblay J; Dupré J; Poitras P; Fournier H; Garon J; Garrel D; Bayard F; Taillefer R
N Engl J Med; 1992 Oct; 327(14):974-80. PubMed ID: 1325608
[TBL] [Abstract][Full Text] [Related]
37. Assay of unbound cortisol in plasma.
Robin P; Predine J; Milgrom E
J Clin Endocrinol Metab; 1978 Feb; 46(2):277-83. PubMed ID: 750605
[TBL] [Abstract][Full Text] [Related]
38. Dissociation of plasma cortisol and ACTH responses to dexamethasone in healthy subjects.
Sherman BM; Schlechte JA; Pfohl BM
Horm Res; 1984; 20(3):157-65. PubMed ID: 6092256
[TBL] [Abstract][Full Text] [Related]
39. Plasma 16 beta-hydroxydehydroepiandrosterone in normal and pathological conditions in man.
Sekihara H; Sennett JA; Liddle GW; McKenna TJ; Yarbro LR
J Clin Endocrinol Metab; 1976 Nov; 43(5):1078-84. PubMed ID: 186475
[TBL] [Abstract][Full Text] [Related]
40. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
